Use of PB-Cre4 Mice for Mosaic Gene Deletion
暂无分享,去创建一个
[1] Kun Xu,et al. Differentiation of the ductal epithelium and smooth muscle in the prostate gland are regulated by the Notch/PTEN-dependent mechanism. , 2011, Developmental biology.
[2] M. Schmidt-Supprian,et al. Persistent inflammation leads to proliferative neoplasia and loss of smooth muscle cells in a prostate tumor model. , 2011, Neoplasia.
[3] A. Ashworth,et al. Brca2 and Trp53 Deficiency Cooperate in the Progression of Mouse Prostate Tumourigenesis , 2010, PLoS genetics.
[4] E. Casanova,et al. A Probasin‐MerCreMer BAC allows inducible recombination in the mouse prostate , 2009, Genesis.
[5] A. Clarke,et al. K-ras and Wnt signaling synergize to accelerate prostate tumorigenesis in the mouse. , 2009, Cancer research.
[6] P. Chambon,et al. Temporally controlled ablation of PTEN in adult mouse prostate epithelium generates a model of invasive prostatic adenocarcinoma , 2008, Proceedings of the National Academy of Sciences.
[7] J. Resau,et al. Inactivation of Apc in the mouse prostate causes prostate carcinoma. , 2007, Cancer research.
[8] David C. Corney,et al. Synergy of p53 and Rb deficiency in a conditional mouse model for metastatic prostate cancer. , 2006, Cancer research.
[9] W. D. Martin,et al. Conditional expression of human 15-lipoxygenase-1 in mouse prostate induces prostatic intraepithelial neoplasia: the FLiMP mouse model. , 2006, Neoplasia.
[10] T. H. van der Kwast,et al. Targeted biallelic inactivation of Pten in the mouse prostate leads to prostate cancer accompanied by increased epithelial cell proliferation but not by reduced apoptosis. , 2005, Cancer research.
[11] N. Greenberg,et al. Conditional Deletion of Rb Causes Early Stage Prostate Cancer , 2004, Cancer Research.
[12] L. Montoliu,et al. Size Matters: Use of YACs, BACs and PACs in Transgenic Animals , 2001, Transgenic Research.
[13] P. Pandolfi,et al. Pten Dose Dictates Cancer Progression in the Prostate , 2003, PLoS biology.
[14] P. Nelson,et al. Prostate-specific deletion of the murine Pten tumor suppressor gene leads to metastatic prostate cancer. , 2003, Cancer cell.
[15] L. Houdebine. The methods to generate transgenic animals and to control transgene expression. , 2002, Journal of biotechnology.
[16] T. Sasaki,et al. T cell-specific loss of Pten leads to defects in central and peripheral tolerance. , 2001, Immunity.
[17] P. Roy-Burman,et al. Generation of a prostate epithelial cell-specific Cre transgenic mouse model for tissue-specific gene ablation , 2001, Mechanisms of Development.
[18] R. Matusik,et al. A small composite probasin promoter confers high levels of prostate-specific gene expression through regulation by androgens and glucocorticoids in vitro and in vivo. , 2000, Endocrinology.
[19] J. Miyazaki,et al. A novel reporter mouse strain that expresses enhanced green fluorescent protein upon Cre‐mediated recombination , 2000, FEBS letters.
[20] S. Lukyanov,et al. An improved PCR method for walking in uncloned genomic DNA. , 1995, Nucleic acids research.